Chemical Structure (Piflufolastat F18 01)
Piflufolastat F-18 Injection
Product Images NDC 85347-001
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Piflufolastat F-18 (NDC 85347-001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aphelion Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Principal Display Panel (50 mL Vial Label)
This is a description of PYLARIFY TRUVU™ (piflufolastat F 18) Injection, a diagnostic agent for intravenous use. It has an expiration time of 10 hours from the end of synthesis and should be stored upright in a shielded container at 20°C to 25°C. The injection contains radioactive material and a combination of piflufolastat F 18, ascorbic acid, ethanol, and sodium chloride. The recommended dosage should be calculated accurately. The product is sterile, non-pyrogenic, and comes in a multiple-dose vial.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
